Delivery Order SPE2DB22D1017-SPE2DB25FG8EH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,159.65 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,040.74 for Carvedilol ER 10 mg capsules (30-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) under a firm fixed-price contract valued at $15,959.88. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count) valued at $10,541.75. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) valued at $10,167.10 under a firm fixed-price contract type. The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $5,976.74. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,054.82 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,687.29. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on January 10, 2025, with a ceiling value of $1,726.39 and an ultimate completion date of January 13, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and represents a direct procurement of pharmaceutical products to support federal medical supply needs. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $12,904.18 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) under a firm fixed price contract type. The award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive, non-set-aside procurement executed through the company's existing contract vehicle. Performance will take place at AmerisourceBergen's corporate office in...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8EHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) under a firm fixed price contract valued at $1,358.25. The order was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to federal medical procurement, with performance occurring at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The prime contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare systems worldwide. The company's federal contract portfolio demonstrates substantial capability in fulfilling diverse medical supply requirements across multiple therapeutic domains for defense and veteran healthcare systems, positioning it as a key vendor in the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/25/25 |